Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Taking five small dutasteride capsules is the same as taking one larger capsule.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

HASHA is a safe and effective option for chin augmentation.

Dutasteride is a safe and effective treatment for hair loss.

Antidepressants can cause long-term side effects like severe withdrawal symptoms and sexual dysfunction, which can last for months or years after stopping the medication.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Some patients taking antipsychotic medications experience skin reactions, ranging from mild to severe.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

Using minoxidil with microneedling increases hair count for hair loss without serious side effects.

Oral minoxidil may have more cardiovascular risks than topical minoxidil.

Low-dose oral minoxidil effectively promotes hair growth but has associated risks.

Finasteride use may increase depression and suicide risk, especially at 1 mg, so monitoring is advised.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Oral minoxidil may help with pediatric hair disorders but has notable side effects.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Laser hair removal is popular for long-term hair reduction but carries risks, requiring well-trained operators and better regulations, especially in South Africa.

Nail changes from immunotherapy can be managed without stopping cancer treatment.

Topical finasteride is an effective and safer treatment for male hair loss.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.